Create your page here
Latest News for: gsk
Edit
A Total of USD 12.7 Million Investment in New Diagnostics and Drug Development for NTDs and Malaria to Partners Including the Ohio State University, PATH, GSK and Others
PR Newswire 30 Jan 2025
TOKYO, Jan ... The GHIT Fund will also invest in two malaria projects ... falciparum malaria under the partnership of Program for Appropriate Technology in Health (PATH), GSK Global Health, Eisai and Ehime University ... Appendix 1. Project Details. ID. G2023-202 ... .
Edit
GSK commits £50m to cancer vaccine research with Oxford University
The Times/The Sunday Times 28 Jan 2025
GSK, one of Britain’s two big pharmaceutical companies, has agreed to invest up to £50 million in a new research collaboration with the University of Oxford focused on preventing cancer through vaccines.
Edit
Depemokimab accepted for review by the European Medicines Agency for use in asthma with type 2 inflammation and CRSwNP (GSK plc)
Public Technologies 28 Jan 2025
GSK plc (LSE/NYSE. GSK) today announced that the European Medicines Agency has accepted for review the Marketing Authorisation Application for the use of depemokimab in two indications ... About GSK ... Find out more at gsk.com.
Edit
Depemokimab applications accepted for review in China and Japan for asthma with type 2 inflammation and CRSwNP (GSK plc)
Public Technologies 28 Jan 2025
Edit
Depemokimab accepted for review by the European Medicines Agency for use in asthma with type 2 inflammation and CRSwNP (Form 6-K) (GSK plc)
Public Technologies 28 Jan 2025
Edit
Depemokimab applications accepted for review in China and Japan for asthma with type 2 inflammation and CRSwNP (Form 6-K) (GSK plc)
Public Technologies 28 Jan 2025
Edit
Angus Planning Ahead: Gatehouse upgrade and farmland battery plant proposal
The Courier 28 Jan 2025
Edit
GSK and Oxford establish the GSK Oxford Cancer Immuno Prevention Programme to advance novel cancer research (GSK plc)
Public Technologies 27 Jan 2025
GSK plc (LSE/NYSE. GSK) and the University of Oxford (Oxford) today announced that they have entered a new research collaboration focused on the potential of cancer prevention through vaccination ... Tony Wood, Chief Scientific Officer, GSK, said.
Edit
Oxford and GSK launch £50million immuno-prevention programme to advance novel cancer research (University of Oxford)
Public Technologies 27 Jan 2025
Edit
GSK and Oxford researchers to create cancer vaccine to stop disease developing
Belfast Telegraph 27 Jan 2025
Edit
GSK signs £50m deal with Oxford University on cancer vaccines
The Guardian 27 Jan 2025
GSK has said it will spend £50m on a project with the University of Oxford to ...
Edit
Cancer vaccine being created by Oxford University and GSK scientists could stop disease up to ...
The Independent 27 Jan 2025
A new partnership ...
Edit
GSK strikes £50m deal with Oxford University on cancer vaccines; dollar rises after Trump U-turn ...
The Guardian 27 Jan 2025
Oxford University hails partnership as ‘step forward in cancer research’. The pan-European Stoxx 600 has lost 0.75% this morning, with technology stocks down by 4.5% ... ....
Edit
GSK's Shingrix new prefilled syringe presentation accepted for review by European Medicines Agency (Form 6-K) (GSK plc)
Public Technologies 27 Jan 2025- 1
- 2
- Next page »